It is also worth mention that several independent clinical trials on CRC not only indicated a decreased expression of PHD3 and FIH, but also revealed their association with higher tumor grade and metastasis [27, 45, 46, 49, 50]. This evidence concerns the gene CASR and colorectal carcinoma.